InvestorsHub Logo
Followers 29
Posts 2139
Boards Moderated 0
Alias Born 05/03/2020

Re: Leronlimab4DaWin post# 131381

Thursday, 12/03/2020 1:13:19 PM

Thursday, December 03, 2020 1:13:19 PM

Post# of 233768
Thanks for sharing that PR GoogleP&D. I'm fascinated as the numbers look pretty good with nil side effects. This will bring a potential interesting spin for CYDY holders waiting for HIV approval as this just passed 2b/3 phase.
So instead of immunomodulating the bodies own system to tame the virus that LL does, lenacapavir interrupts the protein surrounding the virus making it mute. In summary, the guns still there, but no bullets.

I'd be interested to hear some thoughts on what the scientists have to say about this. Was under the impression that the HIV can keep replicating, and learning which makes it deadly.

GLTU/A.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News